NM_012448.4:c.*200_*213delTGTGTGTGTGTGTG

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.

The NM_012448.4(STAT5B):​c.*200_*213delTGTGTGTGTGTGTG variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000109 in 617,316 control chromosomes in the GnomAD database, with no homozygous occurrence. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.00017 ( 0 hom., cov: 21)
Exomes 𝑓: 0.000089 ( 0 hom. )

Consequence

STAT5B
NM_012448.4 3_prime_UTR

Scores

Not classified

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.22

Publications

0 publications found
Variant links:
Genes affected
STAT5B (HGNC:11367): (signal transducer and activator of transcription 5B) The protein encoded by this gene is a member of the STAT family of transcription factors. In response to cytokines and growth factors, STAT family members are phosphorylated by the receptor associated kinases, and then form homo- or heterodimers that translocate to the cell nucleus where they act as transcription activators. This protein mediates the signal transduction triggered by various cell ligands, such as IL2, IL4, CSF1, and different growth hormones. It has been shown to be involved in diverse biological processes, such as TCR signaling, apoptosis, adult mammary gland development, and sexual dimorphism of liver gene expression. This gene was found to fuse to retinoic acid receptor-alpha (RARA) gene in a small subset of acute promyelocytic leukemias (APLL). The dysregulation of the signaling pathways mediated by this protein may be the cause of the APLL. [provided by RefSeq, Jul 2008]
STAT5B Gene-Disease associations (from GenCC):
  • growth hormone insensitivity syndrome with immune dysregulation
    Inheritance: SD Classification: DEFINITIVE Submitted by: Illumina
  • growth hormone insensitivity syndrome with immune dysregulation 2, autosomal dominant
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • growth hormone insensitivity with immune dysregulation 1, autosomal recessive
    Inheritance: AD, AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet, G2P
  • growth hormone insensitivity syndrome
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_012448.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
STAT5B
NM_012448.4
MANE Select
c.*200_*213delTGTGTGTGTGTGTG
3_prime_UTR
Exon 19 of 19NP_036580.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
STAT5B
ENST00000293328.8
TSL:1 MANE Select
c.*200_*213delTGTGTGTGTGTGTG
3_prime_UTR
Exon 19 of 19ENSP00000293328.3P51692
STAT5B
ENST00000951702.1
c.*200_*213delTGTGTGTGTGTGTG
3_prime_UTR
Exon 20 of 20ENSP00000621761.1
STAT5B
ENST00000415845.2
TSL:4
c.*200_*213delTGTGTGTGTGTGTG
3_prime_UTR
Exon 19 of 19ENSP00000398379.2P51692

Frequencies

GnomAD3 genomes
AF:
0.000172
AC:
25
AN:
145740
Hom.:
0
Cov.:
21
show subpopulations
Gnomad AFR
AF:
0.000249
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000228
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000891
AC:
42
AN:
471576
Hom.:
0
AF XY:
0.0000804
AC XY:
20
AN XY:
248628
show subpopulations
African (AFR)
AF:
0.000144
AC:
2
AN:
13910
American (AMR)
AF:
0.0000357
AC:
1
AN:
28030
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
15526
East Asian (EAS)
AF:
0.00
AC:
0
AN:
31060
South Asian (SAS)
AF:
0.00
AC:
0
AN:
49586
European-Finnish (FIN)
AF:
0.0000324
AC:
1
AN:
30836
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2098
European-Non Finnish (NFE)
AF:
0.000128
AC:
35
AN:
273558
Other (OTH)
AF:
0.000111
AC:
3
AN:
26972
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000172
AC:
25
AN:
145740
Hom.:
0
Cov.:
21
AF XY:
0.000170
AC XY:
12
AN XY:
70738
show subpopulations
African (AFR)
AF:
0.000249
AC:
10
AN:
40140
American (AMR)
AF:
0.00
AC:
0
AN:
14404
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3338
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4912
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4526
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9580
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
304
European-Non Finnish (NFE)
AF:
0.000228
AC:
15
AN:
65692
Other (OTH)
AF:
0.00
AC:
0
AN:
1948
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.555
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
15

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.2
Mutation Taster
=100/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs57573850; hg19: chr17-40353542; API